Trump takes on hospitals: the facts behind fight over 340B drug discounts

Does the 340B program raise drug prices? Or does it bolster care for society's poorest? The facts on both sides are more complicated than they appear.

There’s at least one unassailable fact in the battle over the federal 340B drug discount program: $1.6 billion is a lot of money.

That’s how much so-called safety net hospitals will lose from a Trump administration policy, announced last week, to slash reimbursement to providers in the 25-year-old program.

But other facts about the program are muddy. Supporters say the payments help pay for care of poor patients, and that without them more hospitals will shutter. Various hospital groups are now suing to stop the change from taking place on Jan. 1. Detractors, on the other hand, say the program is being abused by some hospitals that use it to increase their profits and market power.

Here’s a deeper look at the facts on each side.

How it works

The 340B the federal government that they serve enough indigent patients.

You're reading a preview, sign up to read more.

More from STAT

STAT4 min read
Opinion: What Roulette And Basketball Can Teach Biogen About Aducanumab
To evaluate if positive results from the EMERGE trial represent a real benefit from aducanumab, and not just a false positive, knowledge of prior evaluations of the amyloid theory need…
STAT4 min read
Opinion: ‘Stuck In A Tornado Of Life’: A Patient’s Chaos Narrative
Medicine prides itself on the pretense of control. The unmoored storylines of chaos narratives threaten the safety of this paradigm and cut through clinicians' psychic defenses. Everyone is vulnerable to…
STAT2 min read
Woman With Novel Pneumonia Virus Hospitalized In Thailand — The First Case Outside China
Health authorities identified a pneumonia case caused by a previously unknown virus in Thailand — the first known infection outside of China.